The retina is the eye’s most sophisticated component. Researchers are developing techniques to recreate retinal tissues — and even entire retinas — in the lab. These complex structures can then be transplanted into patients and could help to restore lost vision in people affected by diseases such as age-related macular degeneration.
Read more at https://www.nature.com/collections/yvwsxqgynv
It seems to me that you are personally involved in this and since you look like a kind and grateful soul, I will try to provide some more information. Unfortunately, I don't have much time these days but you mentioned actual progress, so I fetched 4 articles of different pieces of news over 2018 and 2017 that have scientific citations in them and some mention actual timelines and not fantasies, of when these therapies are expected to be available to patients. It seems to me, some niche genetic diseases like Huntington's disease and Hemophilia and some eye diseases (with AMD first) will be the first ones to be tackled by genetic therapies aka the new way of curing diseases that traditional medicine cannot.
We live in an amazing time my friend. THIS TIME is definitely not the time to get desperate, things are looking good.
Hello friend, the stem cell approach is in clinical trials currently which means that it can be here in 6-8 years depending on the stage that is in and ofcourse if the treatment as a whole is safe and effective, so far so good though, so don't get your hopes dashed.
Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions.
They aim to correct chemical imbalances of neurotransmitters in the brain that are believed to be responsible for changes in mood and behavior.
Depression Medications (Antidepressants)
These are the most commonly prescribed type of antidepressant.
Serotonin and noradrenaline reuptake inhibitors (SNRIs) are used to treat major depression, mood disorders, and possibly but less commonly attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), anxiety disorders, menopausal symptoms, fibromyalgia, and chronic neuropathic pain.
SNRIs raise levels of serotonin and norepinephrine, two neurotransmitters in the brain that play a key role in stabilizing mood.
Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants. They are effective in treating depression, and they have fewer side effects than the other antidepressants.
SSRIs block the reuptake, or absorption, of serotonin in the brain. This makes it easier for the brain cells to receive and send messages, resulting in better and more stable moods.
They are called "selective" because they mainly seem to affect serotonin, and not the other neurotransmitters.